Percutaneous imaging-guided cryoablation for lung cancer

Lung cancer is the most common major cancer in the world and the leading cause of cancer-related mortality, accounting for 1.59 million deaths every year (1). Treatment intention in lung cancer patients varies with the stage of disease. Curative treatment such as surgical resection with lobectomy (2), with or without adjuvant/neoadjuvant chemotherapy, is usually the best choice for early-stage cancer. On the other hand, advanced-stage disease is usually treated with palliative chemotherapy and radiation, which provides 1-year survival of only 15–35% (3)